Small-cell carcinoma of the urinary bladder. A clinico-pathological study of ten cases

Virchows Archiv

Volumn 445, Issue 3, 2004, Pages 292-297

  Soriano, P ^a   Navarro, S ^a   Gil, M ^a   Llombart Bosch, A ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

c erbB2; Immunohistochemical; Oat cell carcinoma; Small cell carcinoma; Survival; Urinary bladder

Indexed keywords

ANTIBODY; C ERB2 ANTIBODY; CHROMOGRANIN ANTIBODY; CYTOKERATIN 20 ANTIBODY; CYTOKERATIN 34 ANTIBODY; CYTOKERATIN BETA E12 ANTIBODY; HNK 1 ANTIBODY; MONOCLONAL ANTIBODY KI 67; NEURON SPECIFIC ENOLASE ANTIBODY; P53 ANTIBODY; PGP 9.5 ANTIBODY; PROTEIN P53; SYNAPTOPHYSIN ANTIBODY; THYROID HORMONE RECEPTOR BETA; THYROID TRANSCRIPTION FACTOR 1 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGE; AGE AT PRESENTATION; AGED; ARTICLE; BLADDER CARCINOMA; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; MALE; METASTASIS; ONSET AGE; OUTCOMES RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; SEX RATIO; SMALL CELL CARCINOMA; TUMOR LOCALIZATION;

AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CARCINOMA, SMALL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; SEX FACTORS; SOFT TISSUE NEOPLASMS; THYROID HORMONE RECEPTORS ALPHA; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 4644371372     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-004-1041-1     Document Type: Article

References (45)

1. Acs G, Gupta PK, Baloch ZW (2000) Cytomorphology of high-grade neuroendocrine carcinoma of the urinary tract. Diagn Cytopathol 23:92-96
2. Agoff SN, Lamps LW, Philip AT et al (2000) Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol 13:238-242
3. Ali SZ, Reuter VE, Zakowski MF (1997) Small cell neuroendocrine carcinoma of the urinary bladder. A clinicopathologic study with emphasis on cytologic features. Cancer 79:356-361
4. Angulo JC, Lopez JI, Sanchez-Chapado M et al (1996) Small cell carcinoma of the urinary bladder: a report of two cases with complete remission and a comprehensive literature review with emphasis on therapeutic decisions. J Urol Pathol 5:1-19
5. Atkin NB, Baker MC, Wilson GD (1995) Chromosome abnormalities and p53 expression in a small cell carcinoma of the bladder. Cancer Genet Cytogenet 79:111-114
6. Bartek J, Bartkova J, Vojtesek B et al (1991). Aberrant expression of the p53 oncoprotein is a common feature of wide spectrum of human malignancies. Oncogene 6:1699-1703
7. Bastus R, Caballero JM, Gonzalez G et al (1999) Small cell carcinoma of the urinary bladder treated with chemotherapy and radiotherapy: results in five cases. Eur Urol 35:323-326
8. Blomjous CEM, Vos W, De Voogt HJ et al (1989) Small cell carcinoma of the urinary bladder: a clinicopathologic, morphometric, inmunohistochemical, and ultrastructural study of 18 cases. Cancer 64:1347-1357
9. Borghi L, Bianchini E, Altavilla G (1995) Undifferentiated small-cell carcinoma of the urinary bladder: report of two cases with a primary urinary cytodiagnosis. Diagn Cytopathol 13:61-65
10. Charles V, Melody C, Debu T et al (2002) Efficacy and safety of Trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol 20:719-726
11. Cheuk W, Kwan MY, Suster S et al (2001). Immunostaining for thyroid transcription factor-1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas. Arch Pathol Lab Met 125:228-231
12. Cramer SF, Aikawa M, Cebelin M (1981) Neurosecretory granules in small cell invasive carcinoma of the urinary bladder. Cancer 47:724-730
13. Davis BH, Ludwig ME, Cole SR et al (1983) Small cell neuroendocrine carcinoma of the urinary bladder: report of three cases with ultrastructural analysis. Ultrastruct Pathol 4:197-204
14. Esrig D, Spruck CH III, Nichols PW et al (1993) P53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol 143:1389-1397
15. Esrig D, Elmajian D, Groshen S et al (1994) Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med 331:1259-1264
16. Furihata M, Inoue K, Ohtsuki Y et al (1993) High risk human papilloma virus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. Cancer Res 53:4823-4827
17. Grignon DJ, Ro JY, Ayala AG et al (1992) Small cell carcinoma of the bladder. A clinicopathologic analysis of 22 cases. Cancer 69:527-536
18. Grossl NA, Candel AG, Nordbock HA, Grossl AC (1992) Undifferentiated small cell carcinoma of the urinary bladder. South Med J 85:189-192
19. Habuchi T, Takahashi R, Yamada H et al (1993) Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer. Cancer Res 53:3795-3799
20. Helpap B (2002) Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract. Cancer 95:1415-1420
21. Helpap B, Kollermann J (2001) Immunohistochemical analysis of the proliferative activity neuroendocrine tumors from various organs. Are there indications for a neuroendocrine tumor-carcinoma sequence? Virchows Arch 438:86-91
22. Helpap B, Kloppel G (2002) Neuroendocrine carcinomas of the prostate and urinary bladder: a diagnostic and therapeutic challenge. Virchows Arch 440:241-248
23. Iczkowski KA, Shanks JH, Allsbrook WC (1999) Small-cell carcinoma of the urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense gamma-enolase expression. Histopathology 35:150-156
24. Leonard C, Huret JL, GFCO (2002) From cytogenetics to cytogenomics of bladder cancers (in French). Bull Cancer 89:166-173
25. Lopez JL, Angulo JC, Flores N et al (1994) Small cell carcinoma of the urinary bladder. A clinicopathological study of six cases. Br J Urol 73:43-49
26. McRae S, Garcia BM (1997) Cytologic diagnosis of a primary pure oat cell carcinoma of the bladder in voided urine. A case report. Acta Cytol 41:1279-1283
27. Mills SE, Wolfe JT, Weiss MA et al (1987) Small cell undifferentiated carcinoma of the urinary bladder. A light-microscopic, inmunocytochemical, and ultrastructural study of 12 cases. Am J Surg Pathol 11:606-617
28. Nguyen PL, Swanson PE, Jaszcz W et al (1994) Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder: a multivariate survival analysis. Am J Clin Pathol 101:166-176
29. Nicholson RI, Gee JM, Harper ME (2001) EGFR and cancer prognosis. Eur J Cancer 37:9-15
30. Oesterling JE, Brendler CB, Burgers JK et al (1990) Advanced small cell carcinoma of the bladder: successful treatment with combined radical cystoprostatectomy and adjuvant methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy. Cancer 65:1928-1936
31. Oka K, Ishikawa J, Bruner JM et al (1991) Detection of loss of heterozygosity in the p53 gene in renal cell carcinoma and bladder cancer using the polymerase chain reaction. Mol Carcinog 4:10-13
32. Ordoñez NG (2000) Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Am J Surg Pathol 24:1217-1223
33. Partanen S, Asikainen U (1985) Oat cell carcinoma of the urinary bladder with ectopic 3 adrenocorticotropic hormone production. Hum Pathol 16:313-315
34. Podesta AH, True LD (1989) Small cell carcinoma of the bladder: report of five cases with immunohistochemistry and review of the literature with evaluation of prognosis according to stage. Cancer 64:710-714
35. Reyes CV, Soneru I (1985) Small cell carcinoma of the urinary bladder with hypercalcemia. Cancer 56:2530-2533
36. Sarkis AS, Dalbagni G, Cordón-Cardo C et al (1993) Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J Natl Cancer Inst 85:53-59
37. Scholl S, Beuzeboc P, Pouillart P (2001) Targeting HER2 in other tumor types. Ann Oncol 12[Suppl 1]:S81-S87
38. Seidman A, Fornier M, Esteva F et al (2001) Weekly Trastuzumab and Paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2. Immunophenotype and gene amplification. J Clin Oncol 19:2587-2595
39. Sidransky D, Von Eschenbach A, Tsai YC et al (1991) Identification of p53 mutations in bladder cancers and urine samples. Science 25:705-709
40. Soini Y, Turpeenniemi Hujanen T, Kamel D et al (1993) P53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression. Br J Cancer 68:1029-1035
41. Terracciano L, Richter J, Tomillo L et al (1999) Chromosomal imbalances in small cell carcinoma of the urinary bladder. J Pathol 189:230-235
42. Trias I, Algaba F, Condom E, Espanol I et al (2001) Small cell carcinoma of the urinary bladder. Presentation of 23 cases and review of 134 published cases. Eur Urol 39:1385-1390
43. Van Hoeven KH, Artymyshyn RL (1996) Cytology of small cell carcinoma of the urinary bladder. Diagn Cytopathol 14:292-297
44. Viverti L, Bongiovanni M, Groce S et al (2000) 34βE12 cytokeratin immunodetection in the differential diagnosis of small cell tumors of lung. Int J Surg Pathol 8:317-322
45. Wright C, Mellon K, Johnston P et al (1991) Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. Br J Cancer 63:967-970